Docoh
Loading...

NMTR 9 Meters Biopharma

APP
Utility
Compositions and Methods for Potentiating Immune Checkpoint Inhibitor Therapy
25 Nov 21
The present invention provides compositions and methods for treating a patient having cancer, as well as methods for potentiating an immune checkpoint inhibitor therapy.
Jay MADAN, Sandeep LAUMAS
Filed: 19 Mar 19
APP
Utility
Compositions and Methods for Treating Disease Associated with Permeability of Intestinal Epithelium
30 Sep 21
The present invention provides methods for treating disorders associated with intestinal barrier dysfunction and increased intestinal permeability.
JAY MADAN, ANTHONY BLIKSLAGER, Sandeep Laumas
Filed: 10 Jun 21
APP
Utility
Compositions and Methods for Potentiating Immune Checkpoint Inhibitor Therapy
5 Aug 21
The present invention provides compositions and methods for treating a patient having cancer, as well as methods for potentiating an immune checkpoint inhibitor therapy.
Jay MADAN, Sandeep LAUMAS
Filed: 23 Apr 21
GRANT
Utility
Compositions and methods for treating disease associated with permeability of intestinal epithelium
13 Jul 21
The present invention provides methods for treating disorders associated with intestinal barrier dysfunction and increased intestinal permeability.
Jay P. Madan, Anthony Blikslager, Sandeep Laumas
Filed: 12 Feb 18
APP
Utility
Compositions and Methods for Potentiating Immune Checkpoint Inhibitor Therapy
10 Jun 21
The present invention provides compositions and methods for treating a patient having cancer, as well as methods for potentiating an immune checkpoint inhibitor therapy.
Jay MADAN, Sandeep LAUMAS
Filed: 10 Feb 21
APP
Utility
Compositions and Methods for Treating or Preventing Hyperglycemia, Insulin Resistance, and Associated Organ Damage
11 Mar 21
The present invention provides compositions and methods for treating hyperglycemia, insulin resistance, and associated organ damage, including in some embodiments diabetes mellitus (type 1 or 2), metabolic syndrome, obesity, fatty liver diseases, or kidney disease.
Christopher PRIOR, Sandeep LAUMAS
Filed: 8 Apr 19
APP
Utility
Compositions and Methods for Treating or Preventing Intestinal Paracellular Permeability
4 Feb 21
The present invention provides methods and compositions for maintaining and improving the integrity of gastrointestinal epithelial tight junctions, thereby helping to maintain healthy paracellular permeability of the GI epithelium.
Jay P. MADAN
Filed: 25 Feb 19
APP
Utility
Compounds and Methods for Treating Tight Junction Permeability
16 Dec 20
The present invention provides Larazotide derivative compositions that resist protease degradation, and in various embodiments, do not demonstrate an inverse dose response, and/or can be delivered at higher doses without loss of potency or efficacy, thereby allowing improved therapy more desirable dosing schedules.
Jay P. MADAN, Balasingham RADHAKRISHNAN, Sandeep LAUMAS, Christopher PRIOR
Filed: 24 Feb 19
APP
Utility
Compositions and Methods for Treating or Preventing Environmental Enteropathy
27 Nov 19
The present invention provides compositions and methods for treating or preventing environmental enteropathy and associated intestinal damage.
JAY MADAN, OSCAR COLIN STINE
Filed: 11 Feb 18
APP
Utility
Compositions and Methods for Treating Disease Associated with Permeability of Intestinal Epithelium
27 Nov 19
The present invention provides methods for treating disorders associated with intestinal barrier dysfunction and increased intestinal permeability.
JAY MADAN, ANTHONY BLIKSLAGER
Filed: 11 Feb 18
  • 1
Patents are sorted by USPTO publication date, most recent first